DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: LEMTRADA (Campath, alemtuzumab)
       *****************************************************
       #Post#: 2039--------------------------------------------------
       More risks emerge for alemtuzumab in MS
       By: agate Date: April 8, 2018, 8:27 pm
       ---------------------------------------------------------
       From MedPage Today, "More risks emerge for alemtuzumab in MS"
       (April 6, 2018):
  HTML https://www.medpagetoday.com/neurology/multiplesclerosis/72194?xid=nl_mpt_DHE_2018-04-07&eun=g345846d0r&pos=0&utm_source=Sailthru&utm_medium=email&utm_campaign=Daily%20Headlines%202018-04-07&utm_term=Daily%20Headlines%20-%20Active%20User%20-%20180%20days
       *****************************************************